Entity Common Stock, Shares Outstanding of OnKure Therapeutics, Inc. from 14 May 2021 to 11 Mar 2026
- Taxonomy & unit
- dei: shares
- Description
- Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
- Summary
-
OnKure Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 14 May 2021 to 11 Mar 2026.
- OnKure Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 11 Mar 2026 was 13,673,565.
- Source SEC data
- View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)
OnKure Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | 13,673,565 | 11 Mar 2026 | 10-K | 12 Mar 2026 | 2025 | FY | ||
| Q2 2024 | 33,428,808 | -371,980 | -1.1% | 08 Aug 2024 | 10-Q | 13 Aug 2024 | 2024 | Q2 |
| Q1 2024 | 33,420,808 | +8,313,378 | +33% | 26 Mar 2024 | 10-K | 28 Mar 2024 | 2023 | FY |
| Q3 2023 | 33,311,787 | +8,782,141 | +36% | 09 Nov 2023 | 10-Q | 13 Nov 2023 | 2023 | Q3 |
| Q2 2023 | 33,800,788 | +9,321,142 | +38% | 07 Aug 2023 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2023 | 25,107,430 | +648,880 | +2.7% | 21 Mar 2023 | 10-K | 27 Mar 2023 | 2022 | FY |
| Q3 2022 | 24,529,646 | +105,746 | +0.43% | 03 Nov 2022 | 10-Q | 08 Nov 2022 | 2022 | Q3 |
| Q2 2022 | 24,479,646 | +74,319 | +0.3% | 04 Aug 2022 | 10-Q | 09 Aug 2022 | 2022 | Q2 |
| Q1 2022 | 24,458,550 | +172,297 | +0.71% | 17 Mar 2022 | 10-K | 23 Mar 2022 | 2021 | FY |
| Q3 2021 | 24,423,900 | 09 Nov 2021 | 10-Q | 12 Nov 2021 | 2021 | Q3 | ||
| Q2 2021 | 24,405,327 | 06 Aug 2021 | 10-Q | 11 Aug 2021 | 2021 | Q2 | ||
| Q1 2021 | 24,286,253 | 14 May 2021 | 10-Q | 20 May 2021 | 2021 | Q1 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.